30 Years of Groundbreaking Science, Training, and Innovation

Satellite Programs

Everyday Antiplatelet Decisions: Making the Right Choices

Evening Program

09/22/2018 18:30:00 09/22/2018 20:00:00 Everyday Antiplatelet Decisions: Making the Right Choices TCT 2017 true MM/DD/YYYY TCT 2014 Satellite Symposia - Evening Program

Saturday, September 22, 2018
Reception: 6:00 pm  | 
Program: 6:30 pm-8:00 pm
Marriott Marquis San Diego Marina, Pacific Ballroom 14-17

Everyday Antiplatelet Decisions: Making the Right Choices

Everyday Antiplatelet Decisions: Making the Right Choices

Sponsored by Cardiovascular Research Foundation

Supported through an educational grant from Chiesi USA, Inc.

The Cardiovascular Research Foundation is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Cardiovascular Research Foundation designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Deepak L. Bhatt, MD, MPH

Brigham and Women's Hospital

Boston, MA


Pascal Vranckx, MD, PhD

Hartcentrum Hasselt

Hasselt, Belgium


Dominick J. Angiolillo, MD, PhD

University of Florida

Jacksonville, FL


John Bittl, MD

Munroe Regional Medical Center

Ocala, FL


Davide Capodanno, MD, PhD

Azienda Ospedaliero-Universitaria

Catania, Italy


C. Michael Gibson, MS, MD

Beth Israel Deaconess Medical Center

Boston, MA


Roxana Mehran, MD, FACC

The Mount Sinai Hospital

New York, NY


Tullio Palmerini, MD

Policlinico S. Orsola

Bologna, Italy


Matthew J. Price, MD

Scripps Clinic

La Jolla, CA


Daniel I. Simon, MD

University Hospitals Cleveland Medical Center

Cleveland, OH


Gregg W. Stone, MD

NewYork-Presbyterian/Columbia University Medical Center

New York, NY


Marco Valgimigli, MD, PhD


Bern, Switzerland


Robert W. Yeh, MD

Beth Israel Deaconess Medical Center

Boston, MA


6:30 pm

First Decision. Acute Care: When to Use Potent Intravenous P2Y12 Inhibition

Gregg W. Stone

6:40 pm

Case Study #1 (With Discussion): A Case in Which I Wish I had Used Potent IV P2Y12 Inhibition

Dominick J. Angiolillo

6:50 pm

Second Decision. DAPT Duration: What Variables Really Matter When Balancing Ischemic vs Bleeding Risk?

Deepak L. Bhatt

7:00 pm

Case Study #2 (With Discussion): DAPT Duration Decision in a Patient at High-Risk for Ischemia and Bleeding

Tullio Palmerini

7:10 pm

Third Decision. Antiplatelet Monotherapy: Who, Which, When and Why?

Pascal Vranckx

7:20 pm

Case Study #3 (With Discussion): A Case for Antiplatelet Monotherapy?

Marco Valgimigli

7:30 pm

Fourth Decision. DAPT Use After DES in the Patient With Atrial Fibrillation: Practical Recommendations

C. Michael Gibson

7:40 pm

Case Study #4 (With Discussion): Acute and Chronic Management of a Patient With STEMI, High Thrombus Burden and Atrial Fibrillation

Robert W. Yeh

7:50 pm

Unanswered Questions From the Audience

8:00 pm